Alirocumab Praluent® |
Formulary
|
In line with NICE. |
NICE TA393: Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia |
|
Evolocumab Repatha® |
Formulary
|
In line with NICE. |
NICE TA394: Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia |
|